Fate Therapeutics, Inc. (FATE)

ANSYS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	44.92	36.06	41.87	61.33	133.58	167.35
Short-Term Investments	195.51	243.01	273.31	374.89	482.33	315.57
Cash & Short-Term Investments	240.43	279.07	315.18	436.23	615.91	482.92
Cash Growth	-37.31%	-11.46%	-27.75%	-29.17%	27.54%	118.09%
Accounts Receivable	2.41	3.54	1.83	38.48	8.68	5.52
Other Receivables	2	2.1	0.9	0.8	1.1	1.5
Receivables	4.41	5.64	2.73	39.28	9.78	7.02
Prepaid Expenses	3.39	7.2	13.64	26.57	7.73	4.39
Total Current Assets	248.22	291.91	331.54	502.07	633.41	494.32
Property, Plant & Equipment	107.94	110.89	158.51	176.09	162.25	99.39
Long-Term Investments	32.29	27.66	0.98	4.94	100.66	-
Long-Term Deferred Charges	-	-	-	7.2	9.87	13.51
Other Long-Term Assets	10.23	10.24	15.19	15.26	15.26	15.24
Total Assets	398.67	440.69	506.22	705.56	921.46	622.46
Accounts Payable	4.19	9.37	4.72	8.27	8.61	6.28
Accrued Expenses	17.21	21.35	27.51	53.93	42.41	15.56
Current Portion of Leases	6.54	7.42	6.18	5.63	5.58	3.36
Current Unearned Revenue	0.21	0.39	0.69	42.23	21.48	21.14
Other Current Liabilities	-	-	-	4	3.2	39.22
Total Current Liabilities	28.16	38.52	39.09	114.05	81.28	85.56
Long-Term Leases	76.79	77.85	97.36	103.71	109.24	93.94
Long-Term Unearned Revenue	-	-	-	-	27.12	46.02
Other Long-Term Liabilities	5.32	5.6	1.35	3.86	24.97	12.48
Total Liabilities	110.26	121.97	137.8	221.62	242.62	238.01
Common Stock	0.12	0.11	0.1	0.1	0.1	0.09
Additional Paid-In Capital	1,724	1,716	1,580	1,536	1,449	941.22
Retained Earnings	-1,436	-1,398	-1,212	-1,051	-769.08	-556.93
Comprehensive Income & Other	0.19	0.27	0.02	-1.85	-0.76	0.07
Total Common Equity	288.41	318.72	368.41	483.94	678.84	384.44
Shareholders' Equity	288.41	318.73	368.42	483.94	678.84	384.45
Total Liabilities & Equity	398.67	440.69	506.22	705.56	921.46	622.46
Total Debt	83.33	85.27	103.54	109.34	114.82	97.3
Net Cash (Debt)	157.1	193.8	211.64	326.89	501.09	385.62
Net Cash Growth	-44.19%	-8.43%	-35.26%	-34.77%	29.95%	98.26%
Net Cash Per Share	1.33	1.70	2.15	3.38	5.29	4.68
Filing Date Shares Outstanding	114.63	114.6	99.24	98.16	96.43	93.78
Total Common Shares Outstanding	114.6	113.93	98.63	97.29	95.73	87.72
Working Capital	220.06	253.39	292.45	388.02	552.13	408.76
Book Value Per Share	2.52	2.80	3.74	4.97	7.09	4.38
Tangible Book Value	288.41	318.72	368.41	483.94	678.84	384.44
Tangible Book Value Per Share	2.52	2.80	3.74	4.97	7.09	4.38
Machinery	-	38.85	83.29	81.5	53.63	22.25
Construction In Progress	-	-	-	-	-	18.19
Leasehold Improvements	-	59.49	59.04	56.78	52.95	2.7

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q